Medicenna Therapeutics Corp. Share Premium
Medicenna Therapeutics Corp. (MDNAF) had Share Premium of CAD 9.49 million as of 2023-03-31, per its 20-F filed 2023-06-27.
Discontinued › Notes
ifrs-full:SharePremium · last filed 2023-06-27
- 2023-03-31: Share Premium 9.49M CAD.
- 2022-03-31: Share Premium 7.93M CAD.
- 2021-03-31: Share Premium 6.68M CAD.
- 2020-03-31: Share Premium 10.39M CAD.
| Period end | Share Premium |
|---|---|
| 2023-03-31 | 9.49M CAD 20-F · filed 2023-06-27 |
| 2022-03-31 | 7.93M CAD 20-F · filed 2023-06-27 |
| 2021-03-31 | 6.68M CAD 20-F · filed 2022-06-22 |
| 2020-03-31 | 10.39M CAD 40-F · filed 2021-05-28 |